Literature DB >> 26296475

Synthesis of BF₃ catalyzed Mannich derivatives with excellent ee from phenylpropanolamine, study of their antimicrobial activity and molecular docking.

K Chennakesava Rao1, K Easwaramoorthi2, Y Arun3, C Balachandran4, K S Muralidhara Rao2, M Govindhan5, Nobuhiko Emi4, T Prakasam2, P T Perumal6.   

Abstract

Antimicrobial agents 4a-g and 5a-g with very good potency were synthesized with 100% ee from phenylpropanolamine (norephedrine) by BF3 catalyzed three components one pot Mannich reaction in good yields. Obtained compounds were characterized using spectral techniques. Antimicrobial study of these compounds revealed a good to very high potential activity against tested microbes when compared to standard antimicrobial drugs streptomycin and ketoconazole. These synthesized compounds exhibited significant minimum inhibitory concentration (MIC) values against Gram positive and Gram negative bacteria. Amongst compound 4b, 4c, 4d, 4e, 5a, and 5e exhibited very high potent MIC values against tested twelve bacteria and three fungi when compared to control. When subjected to molecular docking, in silico studies revealed significant binding energies ranging from -7.06 to -8.90 kcal/mol for all obtained compounds towards target receptor DNA topoisomerase IV and amongst compounds 4b and 4d have shown maximum binding energies 8.70 and 8.90 kcal/mol, respectively.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DNA topoisomerase IV; Lewis acid catalyzed Mannich reaction; Minimum inhibitory concentration; Phenylpropanolamine; Zone of inhibition

Mesh:

Substances:

Year:  2015        PMID: 26296475     DOI: 10.1016/j.bmcl.2015.07.096

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  A New Class of β-Pyrrolidino-1,2,3-Triazole Derivatives as β-Adrenergic Receptor Inhibitors: Synthesis, Pharmacological, and Docking Studies.

Authors:  Kaliyappan Easwaramoorthi; Jeya A Rajendran; Kella Chennakesava Rao; Chandrasekar Balachandran; Yuvaraj Arun; Sakkarapalayam M Mahalingam; Natarajan Arumugam; Abdulrahman I Almansour; Raju Suresh Kumar; Dhaifallah M Al-Thamili; Shin Aoki
Journal:  Molecules       Date:  2019-09-26       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.